Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › KIR3DL3 as an HHLA2 receptor, anti-HHLA2 antibodies, and uses thereof

KIR3DL3 as an HHLA2 receptor, anti-HHLA2 antibodies, and uses thereof

US Patent 12103972 · Granted Oct 1, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of assessing the efficacy of a test agent for modulating programmed death2025
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2025
Methods for upregulating immune responses using combinations of anti-RGMb and an2024
Antibody molecules to PD-1 and uses thereof2023
Compositions and methods for identification, assessment, prevention, and treatme2023
Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, metho2022
Agents that modulate RGMb-neogenin-BMP signaling and methods of use thereof2022
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2022
Methods and compositions for the treatment of persistent infections and cancer b2022
Agents that modulate immune cell activation and methods of use thereof2022
Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor2022
Methods for upregulating immune responses using combinations of anti-RGMb and an2022